About the Pennington Biomedical Research Center The Pennington Biomedical Research Center is at the forefront of medical discovery as it relates to understanding the triggers of obesity, diabetes, cardiovascular disease, cancer and dementia
Risks Associated With Semaglutide While rare, pancreatitis (inflammation of the pancreas) and gallbladder disease have been linked to GLP-1 agonists, including Ozempic
USD 39.95 Prices may be subject to local taxes which are calculated during checkout Similar content being viewed by others Subjects Data availability ER-IP RNA-Seq data and KPK RNA-Seq have been deposited in the Gene Expression Omnibus (GEO) under accession codes GSE318826 and GSE318827
The use of a dulaglutide, a GLP-1, led to a 14 percent reduction in diagnosis of cognitive dysfunction reported in patients with type 2 diabetes in the REWIND trial [funded by Eli Lilly]
The Bottom Line on Retatrutide While the promise of retatrutide is generating understandable excitement, its essential to help patients navigate the risks